Journal ArticleOPEN ACCESS

Monoclonal Antibody Therapy for COVID-19: A Public Health Perspective from Arkansas

Open Forum Infectious Diseases (2022) 9(1)
DOI: 10.1093/ofid/ofab602
1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

COVID-19 monoclonal antibodies revolutionized the treatment for eligible patients who have tested positive for SARS CoV-2 infection in an ambulatory setting. In this short report, we describe our experience assisting in the distribution of monoclonal antibodies in Arkansas during the summer surge of the delta variant.

Author supplied keywords

Cite

CITATION STYLE

APA

Kothari, A., Borella, E. W., & Smith, M. R. (2022). Monoclonal Antibody Therapy for COVID-19: A Public Health Perspective from Arkansas. Open Forum Infectious Diseases, 9(1). https://doi.org/10.1093/ofid/ofab602

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free